Pharmacological management of anaemia in pregnancy: a review

Shand, Antonia; Austin, Kathryn; Nassar, Natasha; Kidson‐Gerber, Giselle

doi:10.1002/jppr.1648

Cited by 4 publications

(4 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…High portion (5 mg) folate is suggested for ladies at high danger of neural cylinder surrenders (for example past pregnancy with a neural cylinder deformity) or in danger of malabsorption. To medicate B 12 deficiency usually proton pump inhibitor, histamine H 2 -receptor antagonists and metformin used [16].…”

Section: Treatmentmentioning

confidence: 99%

See 1 more Smart Citation

Anemia during Pregnancy and Its Prevalence

Zulkifal¹,

Sarwar²,

Saddique³

et al. 2022

Primary Health Care

View full text Add to dashboard Cite

Anemia is a serious health issue throughout the world affecting both sexes of any age group. This nutritional disease is more common among the pregnant women of developing countries, where it is a major cause of maternal death and negative outcome of pregnancy. Among all anemic types, IDA is most prevalent one and is comprises of about 95% of all anemic cases around the world. In many developing countries it is more common in women of low socio-economic background and with no record of antenatal checkup. There is need for further health educational programs to overcome anemia especially for pregnant females.

show abstract

Section: Treatmentmentioning

confidence: 99%

“…Sometimes in the first trimester, iron deficiency anemia is related to the low birth weight of the child but the development of anemia later is not involved. Maternal anemia or iron deficiency may occur due to less parental care or eating unhealthy food, which may cause similar effects [37].…”

Section: Effect On Young Ones and Effect On Mothermentioning

confidence: 99%

Anemia during Pregnancy and Its Prevalence

Zulkifal¹,

Sarwar²,

Saddique³

et al. 2022

Primary Health Care

View full text Add to dashboard Cite

show abstract

“…Since iron cannot be synthesised by the body, individuals with iron deficiency anaemia require iron supplementation, either through oral or intravenous administration to ensure adequate supply to the body [ 15 ]. It has been shown that the mentioned options offer effective treatment for iron deficiency [ 16 ], but there is a suggestion that oral replacement is recommended as first line of treatment [ 17 ]; and usually taken with vitamin C to optimise iron absorption [ 18 ].…”

Section: Introductionmentioning

confidence: 99%

Retrospective audit compares screening and treatment of pregnancy-related anaemia in regional New South Wales with Australian guidelines

Ebrahim,

Vadive,

Dutton

et al. 2024

BMC Pregnancy Childbirth

View full text Add to dashboard Cite

Background Anaemia during pregnancy is common worldwide. In Australia, approximately 17% of non-pregnant women of reproductive age have anaemia, increasing to a rate of 25% in pregnant women. This study sought to determine the rate of screening for anaemia in pregnancy in regional New South Wales, and to determine whether screening and treatment protocols followed the recommended guidelines. Methods This retrospective study reviewed antenatal and postnatal (48 h) data of women (n = 150) who had a live birth at Bathurst Hospital between 01/01/2020 and 30/04/2020. Demographic data, risk factors for anaemia in pregnancy, antenatal bloods, treatments provided in trimesters one (T1), two (T2) and three (T3), and postpartum complications were recorded. These were compared to the Australian Red Cross Guidelines (ARCG) using descriptive statistics. Results Of the women with screening data available (n = 103), they were mostly aged 20-35yrs (79.6%), 23.3% were obese, 97.1% were iron deficient, 17% were anaemic and only a few (5.3%) completed the full pregnancy screening as recommended by the ARCG while a majority completed only partial screenings specifically Hb levels in T1 (56.7%), T2 (44.7%) and T3 (36.6%). Compliance to oral iron was largely undocumented, but constipation was a common side effect among the women. IV iron was administered in 14.0% of women, approximately 1.75x higher than the recommended rate. Conclusions This study provided useful information about compliance to screening and treatment guidelines for anaemia in pregnancy. We identified the need for improved documentation and communication between various health providers to ensure adequate antenatal care to prevent maternal complications during pregnancy. This will improve patient care and encourage further developments in maternal care, bridging the rural health gap.

show abstract

“…Since iron cannot be synthesised by the body, individuals with iron de ciency anaemia require iron supplementation, either through oral or intravenous administration to ensure adequate supply to the body [19]. It has been shown that the mentioned options offer effective treatment for iron de ciency [20], but there is a suggestion that oral replacement is recommended as rst line of treatment [21]; and usually taken with vitamin C to optimise iron absorption [22].…”

Section: Introductionmentioning

confidence: 99%

Retrospective audit compares screening and treatment of pregnancy-related anaemia in regional New South Wales with Australian guidelines

Ebrahim,

Vadive,

Dutton

et al. 2023

Preprint

View full text Add to dashboard Cite

Background. Anaemia during pregnancy is common worldwide. In Australia, approximately 17% of non-pregnant women of reproductive age have anaemia, increasing to a rate of 25% in pregnant women. This study sought to determine the rate of screening for anaemia in pregnancy in regional New South Wales, and to determine whether screening and treatment protocols followed the recommended guidelines. Methods: This retrospective study reviewed antenatal and postnatal (48hrs) data of women (n=150) who had a live birth at Bathurst Hospital between 01/01/2020 and 30/04/2020. Demographic data, risk factors for anaemia in pregnancy, antenatal bloods, treatments provided in trimesters one (T1), two (T2) and three (T3), and postpartum complications were recorded. These were compared to the Red Cross Haemoglobin Assessment and Optimisation in Maternity Guidelines using descriptive statistics. Results: Of the women with screening data available (n=103), they were mostly aged 20-35yrs (79.6%), 23.3% were obese, 97.1% were iron deficient, 17% were anaemic and only a few (5.3%) completed the full pregnancy screening as recommended by the Red Cross Guidelines while a majority completed only partial screenings specifically Hb levels in T1 (56.7%), T2 (44.7%) and T3 (36.6%). Compliance to oral iron was largely undocumented, but constipation was a common side effect among the women. IV iron was administered in 14.0% of women, approximately 1.75x higher than recommended rate. Conclusions: This study provided useful information about compliance to screening and treatment guidelines for anaemia in pregnancy. We identified the need for improved documentation and communication between various health providers to ensure adequate antenatal care to prevent maternal complications during pregnancy. This will improve patient care and encourage further developments in maternal care, bridging the rural health gap.

show abstract

Pharmacological management of anaemia in pregnancy: a review

Cited by 4 publications

References 36 publications

Anemia during Pregnancy and Its Prevalence

Anemia during Pregnancy and Its Prevalence

Retrospective audit compares screening and treatment of pregnancy-related anaemia in regional New South Wales with Australian guidelines

Retrospective audit compares screening and treatment of pregnancy-related anaemia in regional New South Wales with Australian guidelines

Contact Info

Product

Resources

About